Fibroblast growth factor 23 reduces expression of type IIa Na+/Pi co-transporter by signaling through a receptor functionally distinct from the known FGFRs in opossum kidney cells - PubMed (original) (raw)

Fibroblast growth factor 23 reduces expression of type IIa Na+/Pi co-transporter by signaling through a receptor functionally distinct from the known FGFRs in opossum kidney cells

Xiaomei Yan et al. Genes Cells. 2005 May.

Free article

Abstract

Fibroblast growth factor (FGF) 23 is an important phosphaturic factor that inhibits inorganic phosphate (Pi) reabsorption from the renal proximal tubule. Its overproduction and proteolysis-resistant mutation such as R179Q cause tumor-induced osteomalacia and autosomal dominant hypophosphatemic rickets, respectively. To clarify the signaling mechanisms of FGF23 that mediate the reduction of Pi reabsorption, we inhibited the function of the known FGFRs in opossum kidney (OK-E) cells by expressing a dominant-negative (DN) form of FGFR. OK-E cells, which represent the renal proximal tubular cells, expressed all four known FGFRs. FGF23(R179Q) bound to and activated FGFR2, a prominent FGFR expressed in OK-E cells. The activated receptor transmitted a signal to increase the expression of type IIa Na(+)/Pi co-transporter and the Pi uptake. Expression of FGFR2(DN), which suppresses the major FGFR-mediated signal through the FRS2alpha-ERK pathway, reversed the function of FGF23(R179Q). When FGF23(R179Q) was applied to the basolateral side of polarized OK-E cells, regardless of the FGFR2(DN) expression, the apical Pi uptake decreased significantly. The apical application of FGF23(R179Q) in the polarized cells did not show such decrease but increase. The exogenously expressed FGFR2 was detectable only at the apical membrane. These results suggest that an FGF23 receptor, which is functionally distinct from the known FGFRs, is expressed at the basolateral membrane of OK-E cells.

PubMed Disclaimer

Cited by

Importance of Dietary Phosphorus for Bone Metabolism and Healthy Aging.
Serna J, Bergwitz C. Serna J, et al. Nutrients. 2020 Sep 30;12(10):3001. doi: 10.3390/nu12103001. Nutrients. 2020. PMID: 33007883 Free PMC article. Review.
Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy.
Bergwitz C, Miyamoto KI. Bergwitz C, et al. Pflugers Arch. 2019 Jan;471(1):149-163. doi: 10.1007/s00424-018-2184-2. Epub 2018 Aug 14. Pflugers Arch. 2019. PMID: 30109410 Review.
Klotho and activin A in kidney injury: plasma Klotho is maintained in unilateral obstruction despite no upregulation of Klotho biosynthesis in the contralateral kidney.
Nordholm A, Mace ML, Gravesen E, Hofman-Bang J, Morevati M, Olgaard K, Lewin E. Nordholm A, et al. Am J Physiol Renal Physiol. 2018 May 1;314(5):F753-F762. doi: 10.1152/ajprenal.00528.2017. Epub 2017 Nov 29. Am J Physiol Renal Physiol. 2018. PMID: 29187373 Free PMC article.
Effects of phospho- and calciotropic hormones on electrolyte transport in the proximal tubule.
Lee JJ, Plain A, Beggs MR, Dimke H, Alexander RT. Lee JJ, et al. F1000Res. 2017 Oct 3;6:1797. doi: 10.12688/f1000research.12097.1. eCollection 2017. F1000Res. 2017. PMID: 29043081 Free PMC article. Review.
Identifying the culprit lesion in tumor induced hypophosphatemia, the solution of a clinical enigma.
Slot-Steenks MM, Hamdy NA, van de Sande MA, Vriens D, Cleven AH, Appelman-Dijkstra NM. Slot-Steenks MM, et al. Endocrine. 2016 Dec;54(3):642-647. doi: 10.1007/s12020-016-1092-5. Epub 2016 Oct 5. Endocrine. 2016. PMID: 27709474 Free PMC article.

Fibroblast growth factor 23 reduces expression of type IIa Na+/Pi co-transporter by signaling through a receptor functionally distinct from the known FGFRs in opossum kidney cells - PubMed (original) (raw)